advertisement
DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
Explore the latest findings presented at ERA 2025 in Vienna, Austria, through concise video briefs, where leading experts analyze cutting-edge clinical trial data on emerging nonsteroidal mineralocorticoid receptor antagonist therapy in patients with CKD, T2D, and heart failure.
Episodes 1-3 of 3
Topline Results of the CONFIDENCE Trial
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)Topline Results of the CONFIDENCE Trial
The CONFIDENCE Trial: Data Insights
DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome ManagementThe CONFIDENCE Trial: Data Insights
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
